As Alzheimer's cases rise across the U.S., new treatments and care options are emerging to meet demand. From Eli Lilly's promising drug Donanemab to evolving Medicare Advantage plans, understanding your choices is critical. Private neurology clinics, insurance-covered diagnostics, and long-term memory care options are becoming increasingly accessible to families navigating this challenging condition. Here's a 2025 guide to the best available Alzheimer’s care in the U.S., optimized to help you make informed, cost-effective decisions.

Eli Lilly's Donanemab: The Latest Breakthrough in Alzheimer’s Therapy

Donanemab, developed by Eli Lilly, is one of the most anticipated new Alzheimer’s drugs in the U.S. market. This FDA-reviewed treatment targets amyloid plaques and shows promise in slowing cognitive decline in early-stage Alzheimer’s patients.

Donanemab availability and cost in the USA are top of mind for many families. In 2025, more insurance providers, including select Medicare Advantage plans, are beginning to offer partial coverage for this therapy in approved cases. Patients should consult with certified Alzheimer’s specialists in neurology clinics to determine eligibility.

Hospitals and private neurology clinics in cities like Boston, Houston, and Los Angeles are among the first to offer Donanemab under pilot programs, often in conjunction with diagnostic brain imaging.

Medicare Advantage and Alzheimer’s Care Coverage in 2025

Medicare Advantage Alzheimer’s care coverage has expanded in 2025, now including more outpatient memory support programs, early diagnostic services, and select at-home caregiving support.

Unlike traditional Medicare, Advantage plans often contract with private providers to deliver enhanced benefits. Some providers, such as Humana and UnitedHealthcare, are piloting Alzheimer’s-specific care coordination models that integrate:

Behavioral health monitoring

Medication management

Transportation to neurology visits

Cognitive therapy sessions

Families comparing Alzheimer’s insurance options in 2025 should carefully review annual updates in their plan documents or speak with a licensed insurance advisor.

Private Neurology Clinics: Specialized Alzheimer’s Care Near You

With more families seeking personalized care, private neurology clinics specializing in Alzheimer’s treatment are becoming a preferred choice across the U.S. These clinics typically offer shorter wait times, direct access to specialists, and cutting-edge treatment plans that go beyond standard hospital offerings.

Some of the top-rated neurology centers for Alzheimer’s in the U.S. include:

Cleveland Clinic Lou Ruvo Center for Brain Health (Las Vegas)

Mount Sinai Alzheimer’s Disease Research Center (New York)

Mayo Clinic Department of Neurology (Minnesota)

These facilities are also involved in ongoing clinical trials, giving patients potential early access to innovative medications.

Diagnostic Imaging and Cognitive Testing: What Insurance Covers

Accurate diagnosis is essential for timely intervention. Latest Alzheimer’s diagnostic scans covered by insurance now include PET imaging, amyloid plaque detection, and neurocognitive assessments.

Private insurance providers and Medicare Advantage plans often cover these diagnostics if referred by a board-certified neurologist. Clinics using AI-driven imaging interpretation tools are also seeing increased demand in states like California, Florida, and Texas, where aging populations are expanding.

Patients can often receive these diagnostics through outpatient neurology centers or comprehensive memory care clinics.

Long-Term Memory Care and Insurance Planning in the US

The demand for long-term Alzheimer’s memory care insurance plans is growing rapidly. As of 2025, several insurers have launched new policies designed to cover extended care in specialized facilities.

Popular options include:

Genworth Financial Long-Term Care Insurance

Mutual of Omaha Alzheimer’s Care Policies

Lincoln Financial Memory Care Riders

These plans can offset the high costs of private memory care facilities, which now average $6,000 to $9,000 per month in states like New York, Illinois, and Arizona. Some plans also offer inflation protection, caregiver training, and flexible daily benefit options.

Final Thoughts: Making Informed Choices in Alzheimer’s Care

Choosing the right Alzheimer’s treatment and care plan in 2025 requires a combination of clinical insight and financial planning. Whether you’re evaluating the cost of Donanemab, reviewing what Medicare Advantage will cover, or selecting a private memory care center, it’s essential to consult qualified professionals and stay informed.

From Eli Lilly's Alzheimer’s drug developments to Medicare-covered diagnostic services and private neurology clinic offerings, there are now more options than ever to support your loved one’s cognitive health journey.

Stay proactive, review benefits annually, and leverage available resources to ensure access to the best Alzheimer’s care in the United States today.

By